GlassScriptPhysician profile
George Poiani
NPI 1881654754
$16,992.09
in general payments reported to CMS, 2019-2025
40 companies · $2,611 in 2025
The $2,611 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $2,065 · 2021: $2,374 · 2022: $2,603 · 2023: $2,900 · 2024: $2,647 · 2025: $2,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,507 · Consulting Fee: $400 · Education: $225 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,507.24 |
| Consulting Fee | $400.00 |
| Education | $225.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,035.01 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $1,815.25 | 2019-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,593.83 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,571.42 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Grifols USA, LLC | $887.12 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $712.51 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $684.42 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $640.46 | 2020-2025 | Acthar |
| United Therapeutics Corporation | $593.56 | 2020-2024 | Tyvaso, Orenitram, Remodulin |
| Philips North America LLC | $521.00 | 2021-2024 | (Ak6) Vest Therapy, (8874) Incourage |
| Mylan Specialty L.P. | $511.90 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $397.00 | 2019-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $386.64 | 2019-2021 | |
| Axsome Therapeutics, INC. | $356.33 | 2022-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $333.05 | 2020-2025 | Aralast |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $331.31 | 2019-2022 | |
| Amgen INC. | $323.03 | 2021-2025 | Tezspire, Tavneos |
| Insmed, INC. | $306.67 | 2019-2025 | Arikayce, Brinsupri |
| Pfizer INC. | $284.79 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $266.40 | 2024-2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $175.12 | 2021-2024 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $169.19 | 2019-2023 | |
| Inspire Medical Systems, INC. | $154.69 | 2023-2025 | Inspire |
| Vifor Pharma, INC. | $150.51 | 2024-2025 | Zemaira |
| Covis Pharma Gmbh | $132.86 | 2021-2022 | |
| Verona Pharma, INC. | $122.11 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $78.99 | 2023 | |
| Genentech USA, INC. | $62.96 | 2019-2023 | Xolair |
| Circassia INC. | $61.11 | 2019 | |
| Shire North American Group INC | $52.31 | 2019 | |
| Merck Sharp & Dohme LLC | $46.88 | 2021-2025 | Capvaxive |
| Janssen Pharmaceuticals, INC | $41.93 | 2019-2022 | |
| Pulmonx Corporation | $36.64 | 2025 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Viatris Specialty LLC | $33.24 | 2025 | Yupelri |
| Gilead Sciences, INC. | $25.47 | 2019 | |
| Csl Behring | $25.23 | 2019 | |
| Becton, Dickinson and Company | $25.00 | 2024 | |
| Baxter Healthcare | $17.06 | 2025 | Hillrom - Monarch Airway Clearance System |
| Resmed Corp | $16.59 | 2025 | |
| Mallinckrodt Enterprises LLC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Poiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.